Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 28:7:45293.
doi: 10.1038/srep45293.

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series

Affiliations

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series

Matthew P Humphries et al. Sci Rep. .

Abstract

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and assessed clinicopathological information, together with data from 15 published studies, totalling 1984 cases. By immunohistochemistry we investigated 14 biomarkers (ERα, ERβ1, ERβ2, ERβ5, PR, AR, Bcl-2, HER2, p53, E-cadherin, Ki67, survivin, prolactin, FOXA1) for survival impact. The main histological subtype in our cohort and combined analyses was ductal (81%, 83%), grade 2; (40%, 44%), respectively. Cases were predominantly ERα (84%, 82%) and PR positive (74%, 71%), respectively, with HER2 expression being infrequent (2%, 10%), respectively. In our cohort, advanced age (>67) was the strongest predictor of overall (OS) and disease free survival (DFS) (p = 0.00001; p = 0.01, respectively). Node positivity negatively impacted DFS (p = 0.04). FOXA1 p = 0.005) and AR p = 0.009) were both positively prognostic for DFS, remaining upon multivariate analysis. Network analysis showed ERα, AR and FOXA1 significantly correlated. In summary, the principle phenotype of MBC was luminal A, ductal, grade 2. In ERα+ MBC, only AR had prognostic significance, suggesting AR blockade could be employed therapeutically.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Kaplan-Meier survival analysis.
Kaplan-Meier survival analysis showing the impact of FOXA1 expression on OS (a) and DFS (b), the effect of AR expression on DFS (c) and the impact of AR and FOXA1 co-expression on OS (d) and DFS (e). The number of at risk patients and events over time are displayed under each graph.
Figure 2
Figure 2. Correlative biomarker relationships.
Dendrogram showing biomarker correlations using agglomerative hierarchical clustering with complete linkage (a) with an example protein network (b) showing significant correlation relationships indicated by the thickness of line connections. Nodes range from blue to orange, indicating low to high degree of significance, respectively. P values are displayed on the image.

Similar articles

Cited by

References

    1. Ferlay J. et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. Journal international du cancer 136, E359–386, doi: 10.1002/ijc.29210 (2015). - DOI - PubMed
    1. Giordano S., Cohen D., Buzdar A., Perkins G. & Hortobagyi G. Breast carcinoma in men: a population-based study. Cancer 101, 51–57 (2004). - PubMed
    1. CRUK. Breast cancer incidence in males. Available: http://www.cancerresearchuk.org/health-professional/cancer-statistics/st... Accessed: 18 Aug 2016 (2014).
    1. American Cancer Society: Cancer Facts and Figures 2014. Atlanta, Ga: Avaliable from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/... Accessed 19 Aug 2016. (American Cancer Society 2014).
    1. Stang A. & Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast cancer research and treatment 112, 595–596, doi: 10.1007/s10549-007-9882-3 (2008). - DOI - PubMed

Publication types